Home / Market News / $CTVA
fiscal.ai Corporate Catalyst Impact 65/100 ● negative

Lawsuit Filed Against Corteva and The Dow Chemical Company Over Chlorpyrifos

Nov 9, 2026, 2:37 PM UTC · Primary ticker $CTVA

Corteva and The Dow Chemical Company are facing a new lawsuit alleging their chlorpyrifos products caused Parkinson's disease. This legal action could lead to significant financial liabilities and reputational damage for both companies, particularly given the historical context of the pesticide's development and subsequent phase-out.

A new lawsuit has been filed against Corteva, Inc., Corteva Agriscience LLC, and The Dow Chemical Company in Los Angeles County Superior Court. The plaintiffs allege that chlorpyrifos products, designed and distributed by these companies, are linked to Parkinson's disease. This matters because it exposes both Corteva and Dow to potential significant legal costs, damages, and reputational harm, especially given the long history of the product and Corteva's 2020 phase-out. Short-term, this could create negative sentiment around the stocks, while long-term implications depend on the lawsuit's progression and potential settlement or verdict. A key risk for traders is the uncertainty surrounding the financial impact of such litigation on these chemical giants.

$CTVA negative Primary defendant in lawsuit
$DOW negative Co-defendant, original developer of pesticide
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.